Ignite Creation Date:
2024-05-06 @ 9:54 AM
Last Modification Date:
2024-10-26 @ 12:21 PM
Study NCT ID:
NCT03107052
Status:
TERMINATED
Last Update Posted:
2021-11-09
First Post:
2017-03-23
Brief Title:
A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab TEV-48125 for the Prevention of Cluster Headache
Sponsor:
Teva Branded Pharmaceutical Products RD Inc
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-11
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-23
First Submit QC Date:
April 4 2017
Study First Post Date:
2017-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-05-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-06
Last Update Post Date:
2021-11-09
Last Update Post Date Type:
ACTUAL